Bloch Frederic

Prof. Dr. Bloch Frederic

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2018 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
JMJ. Moyet
J. Moyet
GDG. Deschasse
G. Deschasse
BMB. Marquant
B. Marquant
PMP. Mertl
P. Mertl
BFBloch Frederic
Bloch Frederic

1 October 2021 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
FVFabien Visade
Fabien Visade
GBGenia Babykina
Genia Babykina
FPFrançois Puisieux
François Puisieux
BFBloch Frederic
Bloch Frederic
ACAnne Charpentier
Anne Charpentier
JBJean-Baptiste Beuscart
Jean-Baptiste Beuscart
Objective: To analyze the impact of the number of hospital readmissions on the risks of further hospital readmission and death after adjustment for a range of risk factors. Methods: We performed a multicentre prospective study of the DAMAGE cohort in the Hauts-de-France region of France. Patients aged 75 and over hospitalized initially in an acute geriatric unit (AGU) were included and followed up for 12 months. The risk of hospital readmission was analyzed using a Cox model, and its extension for recurrent events and the risk of death were analyzed using a Cox model for time-dependent variables. Results: A total of 3081 patients were included (mean (SD) age: 86.4 (5.5)). In the multivariate analysis, the relative risk (95% confidence interval [CI]) of hospital readmission rose progressively to 2.66 (1.44; 5.14), and the risk of death rose to 2.01 (1.23; 3.32) after five hospital admissions, relative to a patient with no hospital readmissions. The number of hospital readmissions during the follow-up period was the primary risk factor and the best predictor of the risk of hospital readmission and the risk of death. Conclusion: Hospital readmission is the primary risk factor for further hospital readmissions and for death in older subjects discharged from an AGU.

10 August 2021 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Closed access
PDF file
GDGuillaume Deschasse
Guillaume Deschasse
BFBloch Frederic
Bloch Frederic
EDElodie Drumez
Elodie Drumez
ACAnne Charpentier
Anne Charpentier
FVFabien Visade
Fabien Visade
JBJean-Baptiste Beuscart
Jean-Baptiste Beuscart
There is a need for a mortality score that can be used to trigger advanced care planning among older patients discharged from acute geriatric units (AGUs). We developed a prognostic score for 3- and 12-month mortality after discharge from an AGU, based on a comprehensive geriatric assessment, in-hospital events, and the exclusion of patients already receiving palliative care. Devenir Après la Médecine Aigue Gériatrique (DAMAGE) is a French multicenter, prospective, cohort study. The broad inclusion criteria ensured that the cohort is representative of patients treated in an AGU. The DAMAGE participants underwent a comprehensive geriatric assessment, a daily clinical checkup, and follow-up visits 3 and 12 months after discharge. Multivariable logistic regression models were used to develop a prognostic score for the derivation and validation subsets. A total of 3 509 patients were assessed and 3 112 were included. The patient population was very old and frail or dependant, with a high proportion of deaths at 3 months (n = 455, 14.8%) and at 12 months (n = 1 014, 33%). The score predicted an individual risk of mortality ranging from 1% to 80% at 3 months and between 5% and 93% at 12 months, with an area under the receiving operator characteristic curve in the validation cohort of 0.728 at 3 months and 0.733 at 12 months. Our score predicted a broad range of risks of death after discharge from the AGU. Having this information at the time of hospital discharge might trigger a discussion on advanced care planning and end-of-life care with very old, frail patients. Clinical Trials Registration Number: NCT02949635

1 June 2020 in European Journal of Emergency Medicine
Verified
Journal Article
Closed access
JMJulien Moyet
Julien Moyet
BDBénédicte Douay
Bénédicte Douay
ODOrianne Delattre
Orianne Delattre
SHSanaa Hannat
Sanaa Hannat
CDChristian Defouilloy
Christian Defouilloy
BFBloch Frederic
Bloch Frederic

1 January 2022 in The Journal of nutrition, health and aging
Verified
Journal Article
Open access
PDF file
JMJ. Moyet
J. Moyet
FHF. Helle
F. Helle
GBG. Bourdenet
G. Bourdenet
CJC. Joseph
C. Joseph
BGB. Gubler
B. Gubler
EBE. Brochot
E. Brochot
Introduction Elderly residents of nursing homes (NHs) and long-term care units (LTCUs) have been shown to have a high risk of mortality and morbidity in cases of SARS-CoV-2 infection. The objective of this study was to examine the kinetics of neutralizing antibodies (NAbs) directed against the SARS-CoV-2 virus in residents of the NH and LTCU units of our University Hospital who were identified with positive serology after the first epidemic outbreak. Materials and Methods The participants included were sampled every three months for qualitative serological testing, as well as quantitative testing by neutralization tests using retroviral particles containing the S glycoprotein of SARS-CoV-2. Vaccination using the Comirnaty (Pfizer BNT162b2) vaccine begun before the last serological follow-up. Results The median NAb titer in June 2020 was 80 [40; 60] versus 40 [40; 160] three months later, showing a statistically significant decline (p < 0.007), but remained stable between the three- and six-month timepoints (p = 0.867). By nine months after vaccination, we observed a significant difference between vaccinated residents known to have positive serology before vaccination (SERO+, Vacc+) and those vaccinated without having previously shown COVID-19 seroconversion (SERO−, Vacc+), the latter group showing similar titers to the SERO+, Vacc- participants (p=0.166). The median antibody titer in SERO+, Vacc+ patients increased 15-fold following vaccination. Discussion Humoral immunity against SARS-CoV-2 appears to be persistent in elderly institutionalized patients, with a good post-vaccination response by residents who had already shown seroconversion but a notably diminished response by those who were seronegative before vaccination. To evaluate immunity in its entirety and elaborate a sound vaccination strategy, the cellular immune response via T cells specific to SARS-CoV-2 merits analysis, as this response is susceptible to being affected by immunosenescence.

1 October 2017 in Disability and Health Journal
Verified
Journal Article
Closed access
BFBloch Frederic
Bloch Frederic
JLJean-Eric Lundy
Jean-Eric Lundy
ARAnne-Sophie Rigaud
Anne-Sophie Rigaud